276 related articles for article (PubMed ID: 26468944)
1. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
[TBL] [Abstract][Full Text] [Related]
2. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
3. CCR2
Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
[TBL] [Abstract][Full Text] [Related]
4. Precursor Abundance Influences Divergent Antigen-Specific CD8
Zhang Y; Qiu Z; Sheridan BS; Bliska JB
Infect Immun; 2021 Jul; 89(8):e0026521. PubMed ID: 34031132
[TBL] [Abstract][Full Text] [Related]
5. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.
Zhang Y; Mena P; Romanov G; Bliska JB
Infect Immun; 2014 Jul; 82(7):3033-44. PubMed ID: 24799630
[TBL] [Abstract][Full Text] [Related]
6. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
[TBL] [Abstract][Full Text] [Related]
8. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
9. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
[TBL] [Abstract][Full Text] [Related]
10. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
[TBL] [Abstract][Full Text] [Related]
11. Cell type-specific effects of Yersinia pseudotuberculosis virulence effectors.
Fahlgren A; Westermark L; Akopyan K; Fällman M
Cell Microbiol; 2009 Dec; 11(12):1750-67. PubMed ID: 19681909
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response.
Steele LN; Balsara ZR; Starnbach MN
J Immunol; 2004 Nov; 173(10):6327-37. PubMed ID: 15528372
[TBL] [Abstract][Full Text] [Related]
13. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
15. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
Zhang Y; Bliska JB
Infect Immun; 2010 May; 78(5):2329-41. PubMed ID: 20231414
[TBL] [Abstract][Full Text] [Related]
16. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells.
Bergman MA; Loomis WP; Mecsas J; Starnbach MN; Isberg RR
PLoS Pathog; 2009 Sep; 5(9):e1000573. PubMed ID: 19730693
[TBL] [Abstract][Full Text] [Related]
17. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
18. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
Sheahan KL; Isberg RR
mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
[TBL] [Abstract][Full Text] [Related]
19. "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming.
Rüssmann H; Panthel K
Int J Med Microbiol; 2004 Oct; 294(5):313-7. PubMed ID: 15532990
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
McPhee JB; Mena P; Zhang Y; Bliska JB
Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
